The table set forward shows the ownership structure as of June 30, 2010.
|
|
|
| INVESTOR AB |
40.52 |
| OMNIBUS ACCOUNT W FD: OM80 |
9.73 |
| MPM |
8.20 |
| LIVFÖRSÄKRINGSBOLAGET SKANDIA |
4.00 |
| SEB PRIVATE BANK S.A.,NQI |
3.37 |
| ORKLA ASA |
2.30 |
| Swedbank Robur fonder |
1.86 |
| Handelsbanken fonder inkl XACT |
1.69 |
| NORDEA BANK NORGE NOMINEE |
1.41 |
| ABN AMBRO NORDIC VENTURES |
1.28 |
| SKANDIA FONDER |
1.00 |
| CBLDN-400 SERIES FUNDS |
0.77 |
| CATELLA FONDFÖRVALTNING |
0.72 |
| APOTEKET AB:S PENSIONSTIFTELSE |
0.69 |
| ANDRA AP-FONDEN |
0.67 |
| NORTHEN TRUST COMPANY |
0.63 |
| TREDJE AP-FONDEN |
0.61 |
| |
|
|
Others |
20.55 |
The shares of Swedish Orphan Biovitrum AB (publ) are registered at, and the share register is administered by, VPC AB (Box 78 22, 103 97 Stockholm). Share certificates are not issued. As of June 30, 2010, the total number of shares was 211,898,854.
As of June 30, 2010, there are two outstanding warrant programs and three outstanding share programs in Swedish Orphan Biovitrum. All programs are described in detail on the page for Incentive programs in the Corporate Governance section.
If all warrants are exercised, the number of shares will increase by 699,300 newly-issued shares.
In share program 2008 a maximum of 433,952 shares may be allotted to participants. In addition to these, a maximum of about 143,204 shares can be issued to cover any social security charges.
In share program 2009 a maximum of 380,735 shares may be allotted to participants. In addition to these, a maximum of about 125,643 shares can be issued to cover any social security charges.
In share program 2010 no allocation has yet been made.
Investor AB
Investor is a Nordic-based industrial holding company founded almost one hundred years ago by the Wallenberg family. Investments are made in Northern Europe, the U.S. and Asia. The business concept is to create long-term shareholder value by owning companies with solid potential for value creation and applying its financial strength, experience, knowledge and network to make them best-in-class.
www.investorab.com/
MPM Capital
MPM Capital is one of the world's largest life science-dedicated venture investors. With committed capital under management in excess of $2 billion, MPM Capital is uniquely structured to invest globally in healthcare innovation. MPM invests in biotechnology, specialty pharma, medical technology, and related companies that provide innovative medical products and requisite services to the healthcare industry, irrespective of geography, stage of development and therapeutic area.
www.mpmcapital.com
